The Pharma Data

JANUARY 3, 2021

TLC19 Hydroxychloroquine Liposome Inhalation Suspension was thus incubated, with Phase I clinical trial currently taking place in Taiwan and Australia. Other risks are described in the Risk Factors section of TLC’s annual report on Form 20-F for the year ended December 31, 2019 filed with the U.S.

Clinical Trials 52

Clinical Trials Clinical Trials Containment Development 52

The Pharma Data

MARCH 15, 2022

For the Sarclisa ® subcutaneous formulation delivery, Sanofi has partnered with drug delivery technology innovator company Enable Injections , Inc. to advance the development of a subcutaneous delivery for Sarclisa ® with the goal of offering a unique patient-centric treatment experience. In the U.S.,

Life Science 52

Life Science Antibody Clinical Trials Clinical Trials 52

The Pharma Data

JUNE 26, 2021

The safety profile of PDS in the clinical trial setting is well understood and will continue to be closely monitored. Roche has a robust phase III clinical development programme underway for PDS, including the Portal, Pagoda and Pavilion studies. 9 Both the Pagoda and Pavilion trials are actively recruiting participants.

Drug Delivery 52

Drug Delivery Clinical Trials Clinical Trials Medicine 52

Drug Discovery World

FEBRUARY 5, 2024

Dr Gen Li, Founder and President, Phesi “In 2024, we can expect immunotherapy trials to become a driving force for change in clinical development. In the past 10 years, immunotherapy trials have increased by 430%.

Research 116

Research Gene Sequencing Drug Delivery Systems Trials 116

The Pharma Data

JANUARY 3, 2021

and in Asia and for our R&D pipeline, including the Phase 1 trial of EYP-1901 in wet age-related macular degeneration that is expected to commence in the coming months.”. “We We are excited about the significant potential of these products in both the U.S. EyePoint Pharmaceuticals is headquartered in Watertown, Massachusetts.

Production 52

Production Sales Development Licensing 52

Drug Discovery World

JANUARY 12, 2023

Here, Thomas reflects specifically on Anita Cooper’s prediction relating to the importance of clinical trials. . Following the launch of Protas, DDW spoke with Protas Chief Executive, Professor Sir Martin Landray, who echoed Cooper’s emphasis on the importance of clinical trial design.

Clinical Trials 97

Clinical Trials Clinical Trials Drugs Trials 97

The Pharma Data

APRIL 12, 2023

The IL-6 pathway plays an important role in the development and progression of UME by promoting blood vessel leakage and inflammation. 11 Roche recently launched two phase III trials in UME based on encouraging phase I safety and efficacy data. 9 UME is a complication of uveitis, a form of eye inflammation.

Antibody 40

Antibody In-Vitro Development Trials 40

The Pharma Data

DECEMBER 17, 2020

Patient enrollment of EXCELLENCE pivotal trial reaches 98%. The trial remains on-track to complete enrollment of all 500 patients in the United States and Australia before the end of 2020, despite the worsening of the COVID-19 pandemic. The Phase I clinical trial is ongoing in Taiwan in Australia, with results expected in 2021.

Clinical Trials 40

Clinical Trials Clinical Trials Trials Containment 40

Delveinsight

NOVEMBER 29, 2020

Therapies such as dexamethasone drug delivery system and vascular endothelial growth factor inhibitors have already pierced deeper into the market. BioSeizer formulation of dexamethasone sodium phosphate (DSP), TLC399 is an intravitreal, or in-eye, injection, and is under a larger randomized, double-blind, dose-finding phase II trial.

Marketing 52

Marketing Pharma Companies Drug Delivery Clinical Trials 52

The Pharma Data

JANUARY 17, 2021

The trial is comprised of three dose escalation cohorts ranging from 30 ?g g with five patients in each group, and a total of 15 patients will be enrolled in the trial. ” The Company expects to report initial clinical data from the trial in 2021. . 1 and COX-2. the founder, President and CEO of Sirnaomics.

Gene Expression 52

Gene Expression Trials Production Development 52

Delveinsight

JULY 30, 2021

However, the Crohn’s disease market space experienced strides of research and developments imbibed with continuous innovation in terms of drug delivery platforms, MoAs, and RoAs with an end goal to minimize the numbers of patients experiencing no-response from the treatment.

Marketing 74

Marketing Drug Delivery Development Clinical Trials 74

The Pharma Data

DECEMBER 27, 2020

In these unprecedented times, we are especially grateful for the dedication of our research site staff and trial participants, whose commitment to EXCELLENCE facilitated the advancement of our lead program,” said George Yeh, President of TLC. “We SOUTH SAN FRANCISCO, Calif. and TAIPEI, Taiwan, Dec.

Trials 40

Trials Clinical Trials Clinical Trials Containment 40

Pharmaceutical Technology

MAY 31, 2023

Decoy-20 is under clinical development by Indaptus Therapeutics and currently in Phase I for Hepatocellular Carcinoma. According to GlobalData, Phase I drugs for Hepatocellular Carcinoma have an 81% phase transition success rate (PTSR) indication benchmark for progressing into Phase II.

Drug Delivery Systems 130

Drug Delivery Systems Drug Delivery Bacteria Drugs 130